论文部分内容阅读
目的探讨阿奇霉素序贯疗法对支原体肺炎的临床疗效。方法将80例肺炎支原体肺炎患者随机分成两组,治疗组应用阿奇霉素序贯疗法,对照组应用阿奇霉素传统治疗方案。结果治疗组总有效率82.5%,对照组总有效率77.5%,。治疗组医疗费用(954±117)元,对照组医疗费用(1522±306)元,两组比较差异有统计学意义(P<0.05)。治疗组住院时间(6.9±1.5)d,静脉使用阿奇霉素时间(5.1±1.3)d,对照组住院时间(16.5±2.8)d,静脉使用阿奇霉素时间(13.8±1.7)d,两组比较差异有统计学意义(P<0.05)。结论阿奇霉素治疗支原体肺炎采用序贯疗法行之有效,同时减少患者住院时间和费用,值得临床应用。
Objective To investigate the clinical effect of sequential therapy of azithromycin on mycoplasma pneumonia. Methods Eighty patients with Mycoplasma pneumoniae pneumonia were randomly divided into two groups. The treatment group was treated with azithromycin sequential therapy, while the control group was treated with azithromycin traditional therapy. Results The total effective rate was 82.5% in the treatment group and 77.5% in the control group. The medical expenses of the treatment group (954 ± 117) yuan and the control group (1522 ± 306) yuan, the difference between the two groups was statistically significant (P <0.05). The duration of hospitalization was (6.9 ± 1.5) days in the treatment group, azithromycin in the vein was (5.1 ± 1.3) days in the control group, 16.5 ± 2.8 days in the control group and 13.8 ± 1.7 days in the intravenous group Significance (P <0.05). Conclusion Azithromycin treatment of mycoplasma pneumonia with sequential therapy is effective, while reducing hospitalization time and cost, worthy of clinical application.